Skip to NavigationSkip to content

Novartis exec pushed out over Zolgensma data scandal denies wrongdoing

Published on 21/08/19 at 09:54am

Dr Brian Kaspar, the Novartis exec pushed out of AveXis over the Zolgensma data scandal, has said in a statement that he “categorically denies any wrongdoing.”

Speaking through a lawyer, Kaspar said he “stands proudly behind the safety and efficacy” of the $2.1 million gene therapy Zolgensma, and that he is “prepared to assert his rights and defend his conduct accordingly.”

The statement from law firm Heuston Hannigan, who previously represented Elon Musk, says: “Dr Brian Kaspar is a respected member of the scientific community with an impeccable record. He stands proudly behind the safety and efficacy of the drug that he and his team worked so hard to develop, and which remains an FDA-approved drug that is saving the lives of children who suffer from Spinal Muscular Atrophy.

“He has cooperated with Avexis’ internal investigation, and he categorically denies any wrongdoing. He is prepared to assert his rights and defend his conduct accordingly. Dr Kaspar continues to wish clinicians and the company continued success in the treatment of children with this deadly and devastating disease.”

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches